Cost-effectiveness Evaluation of the Individual vs. Group Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care

Cost-effectiveness Evaluation of the Individual vs. Group Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care (PsicAP-COSTS)

The aim of this study is to compare, in cost-effectiveness terms, a brief transdiagnostic cognitive-behavioural therapy in two different modes, individual and group, with the pharmacological treatment usually administered in Primary Care. Participants between 18 and 65 years old and with, according to the pretreatment evaluation, mild or moderate emotional disorders will be randomly allocated to the three experimental groups. After treatment phase and 6 and 12 months later they will be assessed again. The study hypotheses expect to find (H1) the individual treatment generally more effective than the group one. However, (H2) the group therapy is expected to be more effective than the individual with mild disorders and to get better results in terms of cost-effectiveness. Likewise, (H3) the usual treatment is expected to get the worst cost-effectiveness results. Furthermore, (H4) it is expected to find these results across the follow-up assessments too.

Clinical Trial: Cost-effectiveness Evaluation of the Individual vs. Group Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care

Cost-effectiveness Evaluation of the Individual vs. Group Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care

Recruitment

Summary

Participation Requirements

Description

Tracking Information